Prognostic Role of Adjuvant Chemotherapy in Node-Negative (N0), Triple-Negative (TN), Medullary Breast Cancer (MBC) in the Korean Population

• SeungTaek Lim,

  Affiliation Division of Breast & Thyroid Surgical Oncology, Department of Surgery, College of Medicine, St. Vincent’s Hospital, The Catholic University of Korea, Jungbu-daero 93, Paldal-gu, Suwon-si, Gyeonggi-do, 442-723, Republic of Korea

  ⨯
• Se Ho Park,

  Affiliation Department of Surgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 120-752, Republic of Korea

  ⨯
• Heong Kyu Park,

  Affiliation Breast Cancer Center, Department of Surgery, Gachon University Gill Hospital, 1198, Guwoldong, Incheon, 405-760, Republic of Korea

  ⨯
• Min Hee Hur,

  Affiliation Department of Surgery, Cheil General Hospital and Women`s Healthcare Center, Dankook University College of Medicine, 17 Seoae-ro 1-gil, Jung-gu, Seoul, 100-380, Republic of Korea

  ⨯
• Se Jeong Oh,

  Affiliation Department of Surgery, Incheon St. Mary`s Hospital, College of Medicine, The Catholic University of Korea, 56 Dongsu-ro, Bupyung-gu, Incheon, 403-720, Republic of Korea

  ⨯
• Young Jin Suh

  * E-mail: yjsuh@catholic.ac.kr

  Affiliation Division of Breast & Thyroid Surgical Oncology, Department of Surgery, College of Medicine, St. Vincent’s Hospital, The Catholic University of Korea, Jungbu-daero 93, Paldal-gu, Suwon-si, Gyeonggi-do, 442-723, Republic of Korea

  ⨯